Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 4, 2002, Pages 205-214

  Steerenberg, P A ^a   Beekhof, P K ^a   Feskens, E J M ^a   Lips, C J M ^a   Hoppener J W M ^a   Beems, R B ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Diabetes; Fish oil and ob ob mice

Indexed keywords

FISH OIL; GLUCOSE; INSULIN; LARD; POLYUNSATURATED FATTY ACID; SAFFLOWER OIL; SATURATED FATTY ACID; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEATH; EXTRAMEDULLARY HEMATOPOIESIS; FAT INTAKE; FEMALE; FISH; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIVER; LOW FAT DIET; MALE; MICROSCOPY; MORPHOLOGICAL TRAIT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PIGMENTATION; PRIORITY JOURNAL; SPLEEN; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; SPLEEN;

CARTHAMUS TINCTORIUS; GLYCINE MAX;

EID: 0036700981     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Feskens E.J.: Nutritional factors and the etiology of non-insulin-dependent diabetes mellitus: an epidemiological overview. World Rev. Nutr. Diet. 69: 1-39, 1992.
2. Ebbesson S.O., Kennish J., Ebbesson L., Go O., Yeh J.: Diabetes is related to fatty acid imbalance in Eskimos. Int. J. Circumpolar. Health 58: 108-119, 1999.
3. Feskens E.J., Kromhout D.: Epidemiologic studies on Eskimos and fish intake. Ann. N. Y. Acad. Sci. 683: 9-15, 1993.
4. Feskens E.J., Bowles C.H., Kromhout D.: Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14: 935-941, 1991.
5. Feskens E.J., Virtanen S.M., Rasanen L., Tuomilehto J., Stengard J., Pekkanen J., Nissinen A., Kromhout D.: Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 18: 1104-1112, 1995.
6. von Schacky C.: n-3 fatty acids and the prevention of coronary atherosclerosis. Am. J. Clin. Nutr. 71: 224S-227S, 2000.
7. Storlien LH., Baur L.A., Kriketos A.D., Pan D.A., Cooney G.J., Jenkins A.B., Calvert G.D., Campbell L.V.: Dietary fats and insulin action. Diabetologia 39: 621-631, 1996.
8. Patti M.E., Kahn C.R.: Transgenic animal models: insights into the pathophysiology of NIDDM. Diabetes Reviews 5: 149-164, 1997.
9. Leiter E.H., Herberg L.: The polygenetics of diabesity in mice. Diabetes Reviews 5: 131-148, 1997.
10. Chang A.Y., Wyse B.M., Gilchrist B.J., Peterson T., Diani A.R.: Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Diabetes 32: 830-838, 1983.
11. Pankov Y.A.: Adipose tissue as an endocrine organ regulating growth, puberty, and other physiological functions. Biochemistry (Mosc). 64: 601-609, 1999.
12. Filipsson K., Sundler F., Ahren B.: PACAP is an islet neuropeptide which contributes to glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 256: 664-667, 1999.
13. Fleming T.J., Harrington D.P.: A class of hypothesis test for one and to sample censored survival data. Communications in Statistics 2469-2486, 1981.
14. Donahue R.P., Prineas R.J., Donahue R.D., Zimmet P., Bean J.A., De Courten M., Collier G., Goldberg R.B., Skyler J.S., Schneiderman N.: Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study. Diabetes Care 22: 1092-1096, 1999.
15. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E.: Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 21: 494-500, 1998.
16. Luo J., Rizkalla S.W., Vidal H., Oppert J.M., Colas C., Boussairi A., Guerre Millo M., Chapuis A.S., Chevalier A., Durand G., Slama G.: Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21: 717-724, 1998.
17. McManus R.M.,0 Jumpson J., Finegood D.T., Clandinin M.T., Ryan E.A.: A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care 19: 463-467, 1996.
18. Rivellese A.A., Maffettone A., Iovine C., Di Marino L., Annuzzi G., Mancini M., Riccardi G.: Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19: 1207-1213, 1996.
19. Fujiwara T., Yoshioka S., Yoshioka T., Ushiyama I., Horikoshi H.: Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558, 1988.
20. Murakami N., Ohta M., Hashimoto K., Kato K., Mizota M., Miwa I., Okuda J., Inoue G., Kuzuya H., Nakao K., Imura H.: Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent. Eur. J. Pharmacol. 304: 129-134, 1996.
21. Stevenson R.W., Hutson N.J., Krupp M.N., Volkmann R.A., Holland G.F., Eggler J.F., Clark D.A., McPherson R.K., Hall K.L., Danbury B.H., et al.: Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Diabetes 39: 1218-1227, 1990.
22. Yen T.T.: The antiobesity and metabolic activities of LY79771 in obese and normal mice. Int. J. Obes. 8: 69-78, 1984.
23. Young P.W., Cawthorne M.A., Coyle P.J., Holder J.C., Holman G.D., Kozka I.J., Kirkham D.M., Lister C.A., Smith S.A.: Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Diabetes 44: 1087-1092, 1995.
24. Lin P.Y., Romsos D.R., Leveille G.A.: Food intake, body weight gain, and body composition of the young obese (ob/ob) mouse. J. Nutr. 107: 1715-1723, 1977.
25. Mori Y., Murakawa Y., Katoh S., Hata S., Yokoyama J., Tajima N., Ikeda Y., Nobukata H., Ishikawa T., Shibutani Y.: Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 46: 1458-1464, 1997.
26. Miura T., Ohnishi Y., Takagi S., Sawamura M., Yasuda N., Ishida H., Tanigawa K., Yamori Y., Seino Y.: A comparative study of high-fat diet containing fish oil or lard on blood glucose in genetically diabetic (db/db) mice. J. Nutr. Sci. Vitaminol. (Tokyo) 43: 225-231, 1997.
27. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P.: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
28. Hoppener J.W., Oosterwijk C., Nieuwenhuis M.G., Posthuma G., Thijssen J.H., Vroom T.M., Ahren B., Lips C.J.: Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42: 427-434, 1999.
29. Cunnane S.C., McAdoo K.R., Horrobin D.F.: n-3 Essential fatty acids decrease weight gain in genetically obese mice. Br. J. Nutr. 56: 87-95, 1986.
30. Islin H., Capito K., Hansen S.E., Hedeskov C.J., Thams P.: Ability of omega-3 fatty acids to restore the impaired glucose tolerance in a mouse model for type-2 diabetes. Different effects in male and female mice. Acta Physiol. Scand. 143: 153-160, 1991.
31. Appel M.J., Wijnands M.V., Woutersen R.A.: Effects of dietary galactooligosaccharide on azaserine-induced acinar pancreatic carcinogenesis in male Wistar rats. Nutr. Cancer 29: 35-41, 1997.